InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Alhydrogel® adjuvant 2% | Leptospira Lipid A Is a Potent Adjuvant That Induces Sterilizing Immunity aga... | 2023 | Vaccines (Basel) | Varma V.P. et al. | DOI: 10.3390/vaccines11121824 |
| PlasmoTest™ - Mycoplasma Detection Kit | Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That I... | 2023 | Cancer Res Commun. | Kazi A. et al. | DOI: 10.1158/2767-9764.CRC-23-0222 |
| RAW-Lucia™ ISG Cells | Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrins... | 2023 | J Immunother Cancer | Li J. et al. | DOI: 10.1136/jitc-2023-007625 |
| QUANTI-Luc™: Luciferase Detection Reagent | Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrins... | 2023 | J Immunother Cancer | Li J. et al. | DOI: 10.1136/jitc-2023-007625 |
| Blasticidin | Oxidative and ER stress by elevated insulin biosynthesis and palmitic acid in... | 2024 | J Mol Endocrinol. | Vidrio-Huerta B. et al. | DOI: 10.1530/JME-23-0087 |
| LumiKine™ Xpress hIFN-α 2.0 | Involvement of Interferon Regulatory Factor 7 in Nicotine's Suppression of An... | 2019 | J Neuroimmune Pharmacol. | Han H. et al. | DOI: 10.1007/s11481-019-09845-2 |
| LumiKine™ Xpress hIFN-β 2.0 | Involvement of Interferon Regulatory Factor 7 in Nicotine's Suppression of An... | 2019 | J Neuroimmune Pharmacol. | Han H. et al. | DOI: 10.1007/s11481-019-09845-2 |
| LumiKine™ Xpress hIFN-α 2.0 | Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-l... | 2021 | Nat Commun. | Ban T. et al. | DOI: 10.1038/s41467-021-24609-4 |
| ssPolyU Naked | Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-l... | 2021 | Nat Commun. | Ban T. et al. | DOI: 10.1038/s41467-021-24609-4 |
| LPS-EB (LPS from E. coli O111:B4) | The circadian regulator PER1 promotes cell reprogramming by inhibiting inflam... | 2023 | PLoS Biol. | Katoku-Kikyo N. et al. | DOI: 10.1371/journal.pbio.3002419 |
| MycoStrip® - Mycoplasma Detection Kit | INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence... | 2023 | Cancer Discov. | Dietrich C. et al. | DOI: 10.1158/2159-8290.CD-23-0954 |
| Alhydrogel® adjuvant 2% | Identification of four neutralizing antigenic sites on the enterovirus D68 ca... | 2023 | J Virol. | Dai W. et al. | DOI: 10.1128/jvi.01600-23 |
| Poly(I:C) LMW | The transcription factor Aiolos restrains the activation of intestinal intrae... | 2024 | Nat Immunol. | Yomogida K. et al. | DOI: 10.1038/s41590-023-01693-w |
| R848 (Resiquimod) | A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenic... | 2024 | Antimicrob Agents Chemother. | Kirkland M.E. et al. | DOI: 10.1128/aac.00598-23 |
| Alhydrogel® adjuvant 2% | The Group A Streptococcal Vaccine Candidate VAX-A1 Protects against Group B S... | 2023 | Vaccines (Basel) | McCabe S. et al. | DOI: 10.3390/vaccines11121811 |
| Poly(I:C) (HMW) VacciGrade™ | Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy ag... | 2023 | Vaccines (Basel) | Scheunemann J.F. et al. | DOI: 10.3390/vaccines11050966 |
| NLRP3 inflammasome inhibitor - MCC950 | Inflammasome Activation and IL-1β Release Triggered by Nanosecond Pulsed Elec... | 2024 | J Immunol. | Mazzarda F. et al. | DOI: 10.4049/jimmunol.2200881 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | Disruption of cholesterol homeostasis triggers periodontal inflammation and a... | 2023 | Exp Mol Med. | Tran T.T. et al. | DOI: 10.1038/s12276-023-01122-w |
| Puromycin | The linear ANRIL transcript P14AS regulates the NF-κB signaling to promote co... | 2023 | Mol Med. | Ma W. & Hu J. | DOI: 10.1186/s10020-023-00761-z |
| Alhydrogel® adjuvant 2% | Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses pr... | 2023 | J Clin Invest. | Kawai A. et al. | DOI: 10.1172/JCI166827 |